Cure Research for Ovarian Cancer

Cure Research list for Ovarian Cancer:

The list of research areas and treatments under analysis mentioned in various sources for Ovarian Cancer includes:

• Gene therapy

Medications currently used in research into the treatment of Ovarian Cancer:

Note:You must always seek professional medical advice about any treatment or change in treatment plans.

Some of the different medications being used in the research into treatment of Ovarian Cancer include:

• Raltitrexed
• Tomudex

Curable Types of Ovarian Cancer

Possibly curable or rare types of Ovarian Cancer include:

• Serous cystadenoma
• Mucinous cystadenoma
• Granulosa cell tumour
• more curable types...»

Rare Types of Ovarian Cancer:

Some rare types of Ovarian Cancer include:

• Lynch II syndrome
• Arrhenoblastoma
• Sertoli Leydig cell tumour
• Mixed tumours
• more rare types...»

Latest Treatments for Ovarian Cancer

Some of the more recent treatments for Ovarian Cancer include:

• Chemotherapy
• Radiotherapy
• Cisplatin
• Carboplatin
• more treatments...»

Treatments for Ovarian Cancer

Treatments to consider for Ovarian Cancer may include:

• Surgery
  • Hysterectomy with bilateral salpingo-oophorectomy
  • Surgical lymph node removal
  • Surgical tumor debulking
• Chemotherapy
  • IV chemotherapy
  • Intraperitoneal chemotherapy
• more treatments...»

Cure Research discussion for Ovarian Cancer:

Genes and Disease by the National Center for Biotechnology (Excerpt)

So far, the best opportunity to reduce mortality is through early detection (general screening of the population for BRCA1 and BRCA2 is not yet recommended). However, new strategies to find anticancer drugs are constantly being developed. The latest, called "synthetic lethal screening" looks for new drug targets in organisms such as yeast and fruit flies. In the same way that studies in yeast recently helped to identify the functions of BRCA1 and BRCA2, it is thought that drugs that work in more primative organisms will also be applicable to humans. (Source: Genes and Disease by the National Center for Biotechnology)

What You Need To Know About Ovarian Cancer: NCI (Excerpt)

Scientists are studying ways to detect ovarian cancer before symptoms develop. They are exploring the usefulness of measuring the level of CA 125 , a substance called a tumor marker , which is often found in higher-than-normal amounts in the blood of women with ovarian cancer. They also are evaluating transvaginal ultrasound , a test that may help detect the disease early. (Source: excerpt from What You Need To Know About Ovarian Cancer: NCI)

What You Need To Know About Ovarian Cancer: NCI (Excerpt)

A large-scale study, known as the PLCO (Prostate, Lung, Colorectal, and Ovarian) Cancer Screening Trial, is currently evaluating the usefulness of a blood test for the tumor marker known as CA-125 and a test called transvaginal ultrasound for ovarian cancer screening. (Source: excerpt from What You Need To Know About Ovarian Cancer: NCI)

Medical research for Ovarian Cancer: medical news summaries:

The following medical news items are relevant to medical research for Ovarian Cancer:

• Cancer risk cut with Vitamin D
• Cancer risk decreased with Vitamin D
• Cancer screening tests have a high rate of false positive results
• Dairy consumption linked to increased ovarian cancer risk
• Drug company obtains orphan status for its new cancer drug
• Hormone therapy associated with increased risk of ovarian cancer
• Infertility associated with cancer
• Male cancers influenced by breast cancer gene
• Many promising new cancer drugs are in late-stage trials
• Oral estrogen directly increases the risk of ovarian cancer
• Recent studies involving contraceptive pill risks may be flawed
• Researchers aim to develop a blood test to determine presence of cancer
• The 'pill' also prevents ovarian cancer
• More news »

Clinical Trials for Ovarian Cancer

Some of the clinical trials for Ovarian Cancer include:

• A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid Malignancies - This study is no longer recruiting patients (Current: 23 Nov 2006) - Aroplatin (Liposomal NDDP, L-NDDP)
• OVCA-NAC-P2: Study of Chemotherapy Followed by Cytoreductive Surgery for Ovarian, Tubal and Peritoneal Cancers: JCOG0206 - This study is no longer recruiting patients (Current: 23 Nov 2006) - Neoadjuvant chemotherapy (Paclitaxel and Carboplatin)
• Safety and Efficacy Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - catumaxomab
• ZK-Epo Given With Carboplatin in Patients With Recurrent Ovarian Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - SH-Y03757A (ZK-Epothilone; ZK-219477) with carboplatin
• Tissue Bank of Biological Specimens From Patients With Gynecologic Disease - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
• more trials...»

Evidence Based Medicine Research for Ovarian Cancer

Medical research papers related to Ovarian Cancer include:

• Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer
• Use of fertility drugs and risk of ovarian cancer: Danish Population Based Cohort Study.
• Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup
• Ovarian cancer (advanced)
• Laparoscopy versus laparotomy for FIGO Stage I ovarian cancer
• Effect of adjuvant paclitaxel and carboplatin for advanced stage epithelial ovarian cancer: a population-based cohort study of all patients in western Sweden with long-term follow-up
• Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23257 women with ovarian cancer and 87303 controls
• Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls.
• Is annual screening for ovarian cancer in women with a genetic predisposition a safe alternative to prophylactic surgery?
• Nonplatinum topotecan combinations versus topotecan alone for recurrent ovarian cancer: results of a phase III study of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study Gr
• Topotecan for ovarian cancer
• Interval debulking surgery for advanced epithelial ovarian cancer
• Dicer, Drosha, and Outcomes in Patients with Ovarian Cancer.
• Effect of quality of gynaecological ultrasonography on management of patients with suspected ovarian cancer: a randomised controlled trial.
• Survival of ovarian cancer patients in Denmark: excess mortality risk analysis of five-year relative survival in the period 1978-2002
• Do we need to screen ladies for ovarian cancer who have a family history of ovarian ca?
• I need to know the value of using transvaginal ultrasound rather than abdominal ultrasound in detecting ovarian cancer?
• Risk assessment and genetic counseling for hereditary breast and ovarian cancer: recommendations of the National Society of Genetic Counselors.
• An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer.
• Centralization of care for patients with advanced-stage ovarian cancer: a cost-effectiveness analysis
• Intraperitoneal chemotherapy in advanced epithelial ovarian cancer
• Trabectedin (Yondelis) Ovarian cancer ? relapsed, second line
• A meta-analysis of the efficacy of intraperitoneal cisplatin for the front-line treatment of ovarian cancer
• Phase III randomized trial of intravenous cisplatin plus a 24- or 96-hour infusion of paclitaxel in epithelial ovarian cancer: a Gynecologic Oncology Group Study
• Intraperitoneal chemotherapy for patients with advanced ovarian cancer: a review of the evidence and standards for the delivery of care
• Adjuvant chemotherapy for early-stage ovarian cancer: review of the literature.
• Staging and follow-up of ovarian cancer.
• Is there any research from 1970s and 1980s that indicates an increased risk of ovarian cancer by use of IUCDs by 76%?
• A cost-effectiveness analysis of chemotherapy for patients with recurrent platinum-sensitive epithelial ovarian cancer
• Ovarian cancer and hormone replacement therapy in the Million Women Study.

Click here to find more evidence-based articles on the TRIP Database

Search Specialists by State and City